The following issues have been halted by CIRO Company: Helius Minerals Limited TSX-Venture Symbol: HHH All Issues: Yes Reason: Pending News Halt Time (ET): 8:39 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and […]
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire October 23, 2025 LOS ANGELES, Oct. 23, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ:
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on October 23rd — Stocks are little changed early Thursday after the major indices slid yesterday. Easing concerns about U.S.-China trade
— Oramed Advancing Oral Insulin Program Independently; Announces Launch of New U.S. Trial — Diversified Investment Portfolio Delivers Strong Returns — Company Accelerating Growth Through Strategic Partnerships, Innovation, and Value-Driven Expansion — Company Reaffirms Commitment to Rewarding Shareholders, Including Plans for a One-Time Dividend Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (“Oramed” or the “Company”
(NASDAQ:SPRC), TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, recently announced that on September 16, 2025 the board of directors resolved to initiate the launch of an
(NASDAQ:ATYR), MIAMI, Oct. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Shamis & Gentile, P.A. announces that it has filed a class action complaint for violations of the federal securities laws against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) and a senior executive of the Company. The case is pending in the
(NASDAQ:LPLA), SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that Shawn Gentle, AIF(R) of Gentle Family Wealth Partners has joined LPL Financial's broker-dealer and Registered Investment Advisor (RIA) platform. He reported serving approximately $280 million in advisory, brokerage and retirement plan assets* and joins LPL from Raymond James. Based in
Companies Celebrate Longstanding Partnership Representing Nearly a Decade of Innovation and Visionary Leadership RAMSEY, NJ / ACCESS Newswire / October 23, 2025 / Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta), is proud to spotlight the continued success of its longtime partner, PostcardMania, a nationwide marketing technology company headquartered in Clearwater, Florida. Together, the companies
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery GlobeNewswire October 23, 2025 TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, recently announced that
Shamis & Gentile, P.A. has Filed an Expanded Securities Class Action Lawsuit Against aTyr Pharma, Inc. (ATYR) and Alerts Investors of the December 8, 2025 Lead Plaintiff Deadline GlobeNewswire October 23, 2025 MIAMI, Oct. 23, 2025 (GLOBE NEWSWIRE) — The law firm of Shamis & Gentile, P.A. announces that it has filed a class action